• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体切割术前注射贝伐单抗对假晶状体增殖性糖尿病视网膜病变患者玻璃体积血的影响。

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy.

作者信息

Demir Mehmet, Oba Ersin, Can Efe, Kara Orhan, Cinar Sonmez

机构信息

Sisli Etfal Training and Research Hospital, Department of Ophthalmology, Istanbul, Turkey.

出版信息

Ophthalmol Eye Dis. 2013 Jul 15;5:11-5. doi: 10.4137/OED.S12352. Print 2013.

DOI:10.4137/OED.S12352
PMID:23926440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3726581/
Abstract

We evaluated the effect of intravitreal bevacizumab (IVB) injection before pars plana vitrectomy (PPV) on intravitreal hemorrhage (VH) during and after vitrectomy for postoperative the first day and the first month in pseudophakic patients with proliferative diabetic retinopathy (PDR). This retrospective study was performed on 44 eyes of 44 patients who underwent vitrectomy for PDR. Patients were divided into PPV (n = 22 eyes) and PPV + IVB (n = 22 eyes) groups. Injection of bevacizumab (1.25 mg/0.05 mL) was performed 3 days before vitrectomy. Outcomes of visual acuity as well as intraoperative and postoperative VH were compared between the two groups. One month after surgery, visual acuity improved in PPV and PPV + IVB groups (P = 0.005, P = 0.006), respectively. There was no difference between the two groups in best corrected visual acuity at baseline and after vitrectomy (P = 0.71). Intraoperative bleeding into the vitreous was recorded in 14 (63.6%) cases in the PPV group and in 7 (31.8%) cases in the PPV + IVB group. The first month, intravitreal hemorrhage was recorded in six patients in the PPV group and in two patients in the PPV + IVB group (P = 0.03). The mean pre-postoperative central macular thickness was similar in both groups. Intravitreal injection of IVB before vitrectomy decreased the rate of VH at the time of surgery and at the first postoperative month in patients with PDR.

摘要

我们评估了在玻璃体切割术前玻璃体内注射贝伐单抗(IVB)对增殖性糖尿病视网膜病变(PDR)的人工晶状体眼患者玻璃体切割术中及术后第一天和第一个月玻璃体出血(VH)的影响。这项回顾性研究对44例因PDR接受玻璃体切除术的患者的44只眼进行。患者被分为单纯玻璃体切割术(PPV,n = 22只眼)组和玻璃体切割术联合IVB(PPV + IVB,n = 22只眼)组。在玻璃体切割术前3天注射贝伐单抗(1.25 mg/0.05 mL)。比较两组的视力结果以及术中及术后的VH情况。术后1个月,PPV组和PPV + IVB组的视力分别有所改善(P = 0.005,P = 0.006)。两组在基线时和玻璃体切割术后的最佳矫正视力无差异(P = 0.71)。PPV组有14例(63.6%)术中玻璃体出血,PPV + IVB组有7例(31.8%)。在第一个月,PPV组有6例患者发生玻璃体出血,PPV + IVB组有2例患者发生(P = 0.03)。两组术前术后黄斑中心厚度均值相似。玻璃体切割术前玻璃体内注射IVB可降低PDR患者手术时及术后第一个月的VH发生率。

相似文献

1
Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy.玻璃体切割术前注射贝伐单抗对假晶状体增殖性糖尿病视网膜病变患者玻璃体积血的影响。
Ophthalmol Eye Dis. 2013 Jul 15;5:11-5. doi: 10.4137/OED.S12352. Print 2013.
2
Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy.玻璃体切割术前玻璃体腔内注射贝伐单抗对增殖性糖尿病视网膜病变的影响。
Int J Ophthalmol. 2010;3(3):261-3. doi: 10.3980/j.issn.2222-3959.2010.03.19. Epub 2010 Sep 18.
3
The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.辅助玻璃体内注射贝伐单抗预防增生性糖尿病视网膜病变玻璃体切割术后出血的效果。
Ophthalmology. 2011 Nov;118(11):2218-26. doi: 10.1016/j.ophtha.2011.03.036. Epub 2011 Jul 2.
4
Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.玻璃体切割术后玻璃体内注射贝伐单抗和曲安奈德治疗糖尿病性玻璃体积血:一项对照研究。
Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):641-50. doi: 10.1007/s00417-009-1247-7. Epub 2009 Dec 12.
5
Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial.玻璃体内注射贝伐单抗(IVB)对比玻璃体内注射贝伐单抗联合玻璃体切除术治疗增生性糖尿病视网膜病变继发玻璃体积血:一项随机临床试验。
Int J Retina Vitreous. 2021 Apr 26;7(1):35. doi: 10.1186/s40942-021-00296-7.
6
Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.玻璃体内注射贝伐单抗预防糖尿病患者玻璃体切除术后早期出血:一项随机临床试验。
Ophthalmology. 2009 Oct;116(10):1943-8. doi: 10.1016/j.ophtha.2009.07.001. Epub 2009 Aug 21.
7
Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.增生性糖尿病视网膜病变患者行玻璃体切割术,术前单次玻璃体腔内注射或未注射贝伐单抗后的6个月视力转归
Int Ophthalmol. 2012 Apr;32(2):135-44. doi: 10.1007/s10792-012-9541-5. Epub 2012 Mar 27.
8
Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.微创玻璃体切除术联合玻璃体内注射贝伐单抗作为手术辅助治疗糖尿病性牵拉性视网膜脱离。
Ophthalmology. 2009 May;116(5):927-38. doi: 10.1016/j.ophtha.2008.11.005. Epub 2009 Mar 9.
9
Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.玻璃体腔内注射贝伐单抗治疗严重增生性糖尿病视网膜病变的手术治疗。
Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):785-91. doi: 10.1007/s00417-010-1303-3. Epub 2010 Feb 5.
10
Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.评价增生型糖尿病视网膜病变行玻璃体切割术联合术前玻璃体内注射雷珠单抗和术后玻璃体内注射曲安奈德的效果。
Int Ophthalmol. 2021 May;41(5):1635-1642. doi: 10.1007/s10792-021-01703-6. Epub 2021 Feb 4.

引用本文的文献

1
Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.抗血管内皮生长因子联合玻璃体切除术治疗增生性糖尿病视网膜病变并发症。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD008214. doi: 10.1002/14651858.CD008214.pub4.
2
Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy.糖尿病视网膜病变中视网膜炎症的蛋白质组学生物标志物。
Int J Mol Sci. 2019 Sep 25;20(19):4755. doi: 10.3390/ijms20194755.
3
Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (Observational Study).糖尿病性玻璃体积血玻璃体切除术后玻璃体内注射雷珠单抗(观察性研究)。
Medicine (Baltimore). 2019 May;98(20):e15735. doi: 10.1097/MD.0000000000015735.
4
Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis.基于蛋白质组学分析的雷珠单抗诱导增殖性糖尿病视网膜病变患者玻璃体液蛋白质谱的变化
Clin Proteomics. 2018 Mar 9;15:12. doi: 10.1186/s12014-018-9187-z. eCollection 2018.
5
Role of bevacizumab in the prevention of early postoperative haemorrhage after 25-gauge microincision vitrectomy surgery.贝伐单抗在25G微切口玻璃体切除术后预防早期术后出血中的作用
Pak J Med Sci. 2016 Sep-Oct;32(5):1184-1187. doi: 10.12669/pjms.325.10362.
6
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.

本文引用的文献

1
Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion.玻璃体内注射贝伐单抗与曲安奈德治疗视网膜中央静脉阻塞继发黄斑水肿的疗效比较
Indian J Ophthalmol. 2014 Mar;62(3):279-83. doi: 10.4103/0301-4738.105769.
2
Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab.玻璃体切割术对玻璃体内注射贝伐单抗后视网膜分支静脉阻塞所致复发性黄斑水肿的影响。
J Ophthalmol. 2013;2013:415974. doi: 10.1155/2013/415974. Epub 2013 Feb 20.
3
Comparison of wide conjunctival flap and conjunctival autografting techniques in pterygium surgery.
J Ophthalmol. 2013;2013:209401. doi: 10.1155/2013/209401. Epub 2013 Mar 3.
4
Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.玻璃体腔内注射贝伐单抗(阿瓦斯汀)联合全视网膜光凝治疗高危增殖性糖尿病视网膜病变。
J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):550-5. doi: 10.1089/jop.2012.0202. Epub 2013 Mar 15.
5
Comparison of intravitreal triamcinolone acetonide with intravitreal bevacizumab for treatment of diabetic macular edema: a meta-analysis.比较曲安奈德与贝伐单抗玻璃体腔内注射治疗糖尿病黄斑水肿的疗效:一项荟萃分析。
Curr Eye Res. 2013 May;38(5):578-87. doi: 10.3109/02713683.2013.767351. Epub 2013 Feb 13.
6
Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema.弥漫性糖尿病黄斑水肿患者的光学相干断层扫描模式对玻璃体内注射贝伐单抗的视力结果有影响。
Retina. 2013 Apr;33(4):740-7. doi: 10.1097/IAE.0b013e31826b6763.
7
Influence of preoperative intravitreal bevacizumab on visual function in eyes with proliferative diabetic retinopathy.术前玻璃体内注射贝伐单抗对增生型糖尿病视网膜病变眼视力功能的影响。
Ophthalmic Res. 2013;49(1):30-6. doi: 10.1159/000324135. Epub 2012 Sep 29.
8
Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.糖尿病玻璃体切除术后玻璃体内注射贝伐单抗预防术后玻璃体出血的比较研究
J Med Assoc Thai. 2012 Apr;95 Suppl 4:S136-42.
9
Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1α.贝伐单抗对增殖性糖尿病视网膜病变新生血管膜的影响:内皮细胞减少以及血管内皮生长因子(VEGF)和缺氧诱导因子-1α(HIF-1α)表达降低。
Mol Vis. 2012;18:1-9. Epub 2012 Jan 1.
10
[Intravitreal bevacizumab pretreatment in vitrectomy for severe diabetic retinopathy: a series of six cases].
J Fr Ophtalmol. 2012 Apr;35(4):260-5. doi: 10.1016/j.jfo.2011.07.006. Epub 2011 Sep 1.